The Reagan-Udall Foundation for the FDA convened an invitation-only, half-day workgroup meeting attended by representatives of industry, mental health professionals, and patients, in which participants articulated challenges facing mental health interventions and discussed potential solutions. The viewpoints reflected in the discussions and in the resulting report are those of the attendees.

Download Publication
Advancing Digital Mental Health Innovation